IGF-I is a 70 amino acid peptide with growth-promoting activity. Clinically, it is common practice to measure serum or plasma levels of IGF-I by RIA in patients with varying disorders of growth. However, there are frequent and marked discrepancies between levels of IGF-I measured by RIA and growth rate (1) (2) (3) . Newborns show the greatest growth velocity at any age, have increased levels of growth hormone, yet low serum IGF-I values (4) . Prepubertal children grow steadily despite relatively low levels of circulating IGF-I (5).
Variability in IGF-I receptor binding may better explain IGF-I activity in the body. IGF-I resistance with decreased IGF-I binding has been suggested as the underlying cause of short stature in some children (6. 7) . Specific IGF-I receptors are present on a variety of human tissues including fibroblasts (8) . mononuclear cells (9) , ovary (lo), liver (1 1), brain (12) , placenta ( 13) , and erythrocytes (14) (15) (16) tractive to study because they are easily obtainable and require only small sample vol.
In the present study, we compare IGF-I binding to erythrocytes in normal adults and prepubertal children, using a Thr59-IGF-I analog. We wished to assess whether young children had evidence for greater binding of IGF-I to help explain their continuing growth.
MATERIALS AND METHODS
Subjects. We studied 13 normal children, 10 boys and three girls, aged 3 to 10 y. All were prepubertal as determined by the method of Tanner, and all were between the 5th and 95th percentiles for height and wt (17, 18) . We also studied 33 normal nonobese adults, nine men and 24 women, between 20 and 47 y of age. This study was approved by the Human Subjects Committee of Baystate Medical Center, and all subjects and parents signed an informed consent form before participation.
Materials. Lactoperoxidase iodinated (Thr59)-IGF-I, with a sp act of 258 FCi/pgm, was purchased from Amersham Corp. (Arlington Heights, IL). The product is purified by HPLC to give the monoiodinated peptide. Thr59-IGF-I, 127% active versus human IGF-I standard by RIA, was purchased from AMGen Biologicals (Thousand Oaks, CA). The IGF-I analog used in this study differs from natural IGF-I only by the substitution of threonine for methionine at position 59. It has similar binding activity in an erythrocyte-binding assay to natural IGF-I (1 4, 15) . It also behaves similarly to natural IGF-I in RIA systems (19, 20) . Purified pork insulin was kindly provided by Dr. Mary Root of Eli Lilly CO. (Indianapolis, IN). Ficoll-Hypaque was obtained from Sigma Diagnostics (St. Louis, MO).
Separation of erythrocytes. All specimens were obtained between 0800 and 1200 in nonfasting subjects. Blood (15 cc) was collected in sterile heparinized tubes. Cell binding and reticulocyte counts were performed immediately, and serum aliquots were frozen at -20°C until assay. Separation of erythrocytes was accomplished over Ficoll-Hypaque gradient by the method of Gambhir (2 1). After repeated washes in buffered saline, the erythrocytes were resuspended in Hepes buffer, pH 7.4 ( 100-mM Hepes, 120-mM NaC1, 1.2-mM MgS04, 5mM-Na acetate, 10-mM dextrose, 1 mM EDTA, and 1% BSA) to a final mean concentration of 4.88 x lo9 cells/mL as determined by Coulter counter (Coulter Electronics, Inc., Hialeah, FL). Reticulocytes were determined by staining with methylene blue.
Binding studies. A total of 400 of erythrocytes were incubated at 4°C for 18-24 h with 50 ~1 of '251-Thr5'-IGF-I (20 000-30 000 cpm) alone or with the addition of unlabeled IGF-I analog at varying concentrations between 2.5 and 160 ng/mL. The final vol was 500 FL. After incubation, duplicate 200-FL aliquots of suspension were layered over 200 FL of cold 2% BSA Hepes buffer in plastic microtubes. After microcentrifugation in a Beckman Microfuge (Beckman Instruments, Inc., Palo Alto. CA), supernatants were discarded and radioactivity of the pellets measured. Nonspecific binding was defined as that radioactivity that remained in the presence of I pg/mL of IGF-I analog and was subtracted from the total binding determination to yield specific binding. Nonspecific binding was 6.3 t 0.4% (mean ? SEM) of the total radioactivity added. Results were normalized to 3 x lo9 cells/mL. Intra-and interassay coefficients of variation were 3.1 % and 16.5%, respectively.
In five normal nonobese adults, specificity of '251-Thr5'-IGF-I binding for IGF-I receptors was measured by the ability of unlabeled insulin (2.5-10,000 ng/mL to inhibit 1251-ThrS'-IGF-I binding.
Specific IGF-I levels were measured by RIA at Endocrine Sciences (Tarzana, CA). The RIA was conducted using serum samples after chromatography on Sephadex G-50 columns in 0.25-M formic acid. This acid chromatography step yields a fraction containing over 95% of the applied IGF-I activity with no detectable binding protein activity (22) .
Statistical unalys~s. Analysis of ligand binding data was performed using the Ligand-PC curve fitting and data analysis software program developed by Munson and Rodbard at the National Institutes of Health. Statistical significance for all data was calculated by the 2-tailed Student's t test with appropriate assessment for equality of variance and linear regression analysis.
RESULTS
In the prepubertal children, the specific 1251-Thr5'-IGF-I binding to red blood cells of 13.9 ? 0.7% (mean t-SEM, with a range from 9.2 to 19%) was significantly higher ( p = 0.01) than the 11.6 rt 0.5% value for the adults (range, 7.1-17.5%) ( Table I) .
Specific binding did not differ between adult males and females, nor was there a significant correlation between specific binding and reticulocyte count (range, 0.3-3.0%) in either the adults or children (data not shown). Serum IGF-I levels did not differ between the two groups; all subjects had levels in the normal range for age. Figure 1 shows the displacement of 12SI-IGF-I analog by increasing concentrations of either unlabeled IGF-I analog or insulin in adults and children. At each concentration of IGF-I, there was significantly more displacement of the tracer in children than in adults. Half maximal displacement occurred at an IGF-I concentration of about 20 ng/mL in the adults and at about 10 ng/mL in the children. An approximately 500-fold concentration of insulin over that of unlabeled Thr5'-IGF-I was required to inhibit '251-Thr59-IGF-I binding.
Scatchard analysis revealed linear plots for both prepubertal children and adults (Fig. 2) . The mean value, 4.97 X lo8 M-', for the affinity constant in the prepubertal children was significantly greater ( p = 0.03) than in adults, 3.70 x lo8 M-' (Table  1) 
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There was a highly significant correlation ( p = 0.007, r = 0.39) between specific 1'51-Thr5~IGF-I binding and the affinity constant when all subjects were assessed (Fig. 3) . This correlation exists within the adult group alone, but does not reach statistical significance in the data from the prepubertal children. However, there was no relation between labeled Thr5'-IGF-I binding and circulating serum IGF-I levels (Fig. 4) or receptor concentration (data not shown).
DISCUSSION
Previous studies have demonstrated specific IGF-I binding to red blood cells (14) (15) (16) . As further evidence, aIR-3, a mouse MAb that specifically binds to the type 1 IGF-I receptor, significantly inhibits IGF-I binding to the erythrocyte (23) . We have also confirmed the specificity of 1251-Thr59-IGF-I binding to erythrocytes by showing that insulin was only about 0.2% as potent as unlabeled Thr5'-IGF-I in inhibiting tracer binding.
Although the mature red blood cell has no nucleus, previous studies with insulin binding show that it is an acceptable tissue for evaluating changes in insulin receptor affinity and long-term changes in receptor concentration (24) . Given the significant structural homology between insulin and IGF-I and their respective receptors (25, 26) , erythrocytes also should be valid to study IGF-I binding. Additionally, Izumi el al. (14) described patients with insulin receptor abnormalities who have decreased numbers IGF-I (U/ml) Fig. 4 . The relationship between serum IGF-I levels and specific 12'I-ThrS'-IGF-I binding to erythrocytes from adults and prepubertal children. Thc correlation coefficicnt was not statistically significant. 
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